20
May
2025

Shijiazhuang Lonzeal Pharmac.Co. ltd

Exhibitor at CPHI Americas 2025 stand 1638
About Us

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. was founded on December 30th 2006. Lonzeal’s current core business is research and development, production and sales of anti-AIDS and hepatitis B drugs. We are now one of the most competitive manufacturers of anti-retrovirus (ARV for HIV and HBV) drugs in China, with product registration at international drug authorities including WHOPQ, China, India, Russia, Brazil and South Africa.

  • CN
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Contact info
Event information
CPHI Americas 2025
  • 20 May 2025 - 22 May 2025
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 1638

Products Featured at CPHI Americas 2025

  • Baloxavir Marboxil

    Product Baloxavir Marboxil

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Baloxavir Marboxil. Product not provided to where patent is still valid
  • Pregabalin

    Product Pregabalin

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Pregabalin.
  • Emtricitabine

    Product Emtricitabine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes Emtricitabine.
  • Lamivudine

    Product Lamivudine

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine. It belongs to antiviral drugs APIi category. APIplication: anti-viral drug substance. Contact us for more information.
  • Tenofovir Alafenamide Fumarate(TAF)

    Product Tenofovir Alafenamide Fumarate(TAF)

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes TAF.  Product not provided to where patent is still valid
  • Tenofovir Disoproxil Fumarate (TDF)

    Product Tenofovir Disoproxil Fumarate (TDF)

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes tenofovir disoproxil fumarate (tdf). It belongs to antiviral drugs APIi category. APIplication: anti-viral drug substance. Contact us for more information.
  • Paroxetine Hydrochloride

    Product Paroxetine Hydrochloride

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes paroxetine hydrochloride. APIplication: antidepressant drug substance. Contact us for more information.
  • Lamivudine Intermediate CME

    Product Lamivudine Intermediate CME

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine intermediate cme. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • Lamivudine Intermediate CTS

    Product Lamivudine Intermediate CTS

    Lamivudine Intermediate CTS
  • Lamivudine Intermediate HME

    Product Lamivudine Intermediate HME

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine intermediate hme. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • Lamivudine Intermediate MGH

    Product Lamivudine Intermediate MGH

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes lamivudine intermediate l-mgh. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • TDF Intermediate PMPA

    Product TDF Intermediate PMPA

    Shijiazhuang Lonzeal Pharmaceuticals Co Ltd offers a wide range of products which includes TDF intermediate pmpa. It belongs to antiviral drugs intermediates category. APIplication: antiviral intermediates. Contact us for more information.
  • Lamivudine Tablets
  • Pregabalin Capsules

    Product Pregabalin Capsules

    25mg/50mg/75mg/100mg/150mg
  • Tenofovir Alafenamide Fumarate Tablets

    Product Tenofovir Alafenamide Fumarate Tablets

    25mg.  Product not provided to where patent is still valid